TESLA SWING LONG IDEA - TSLA We had a great run on Tesla after Trump's election, which boosted the idea of Robotaxi and green earnings over time.
If you follow me on X, you would know that I have been buying Tesla since the $204 level (August 5th crash). We had a great run from there to $490.
Currently, we have seen a 33% retracement from the top.
The price hit the weekly demand zone and showed a strong rejection there (forming a weekly dragonfly doji).
I have started to build a swing position from this level to ride Tesla to new all-time highs.
The first challenge will be the bearish trendline that has been driving the bearish trend since December 18th. Breaking that trendline should lead to new highs, in my opinion.
If the price breaks and closes below $300 on the daily chart, it will invalidate my setup, and I will look to exit the position.
Stocks
#SMTC $SMTC AnalysisNASDAQ:SMTC Key levels:
$35 = Yearly and Biannually demand
$50 = Broken upper channel wedge "Could be retested"
$20 = A cluster og yearly and 6 month demand
#SMTC is trading on a huge yearly and bianually demand where it accumlating more buys. The stock is trading below its 200 SMA and might stall upon retesting it.
Closing below $29 will unlock a zone down to $20 per share.
#smtc #stocks #stockmarket #ahmedmesbah
#Tesla $TSLA is approaching key levels. NASDAQ:TSLA D1
Key levels:
$300: 1 Year demand zone.
$280: 200 SMA + a significant lower channel wedge extending since April 2024.
A bounce from these levels will fuel more momentum to $375 or more.
A weekly close below $270 will unlock a new zone extended down to $230
#TSLA #TESLA #STOCKS #AHMEDMESBAH
META priced the new Channel Up bottom. Eyes $800 next.Meta Platforms (META) hit yesterday its 1D MA50 (blue trend-line) for the first time since January 02, while reaching the bottom of the short-term (dashed) Channel Up and the 1D RSI the November 15 2024 Low.
Since the 2-year pattern is also a Channel Up, this pull-back is a natural technical correction before the next Bullish Leg. Both previous rallies that started after long-term Accumulation Phases, then rallied by at least +45.10%.
As a result, we treat this correction as the most optimal medium-term buy opportunity to target $800 (top of dashed Channel Up and +45.10% from the Accumulation Phase bottom).
-------------------------------------------------------------------------------
** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. **
-------------------------------------------------------------------------------
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
Tesla (TSLA) Share Price Drops by Over 8%Tesla (TSLA) Share Price Drops by Over 8%
The Tesla stock chart today paints a grim picture for investors, as TSLA's price during trading on 25 February:
→ fell by more than 8% in a single day;
→ dropped below the psychologically significant $300 per share mark for the first time since early November 2024 (despite nearing $500 in late December 2024).
Why Tesla (TSLA) Shares Have Fallen
Tesla’s sales in Europe fell by 45% in January compared to the same period last year, even as overall EV sales in Europe grew by 37%.
This sharp drop in European sales has heightened concerns that CEO Elon Musk’s political activities are negatively affecting the company’s business.
Technical Analysis of Tesla (TSLA) Stock Chart
Price movements in 2024 formed a key upward trend channel (marked by blue lines), but yesterday’s decline led to a bearish break below the lower boundary of this trend. Specifically:
→ The $330 level, where the lower blue boundary was breached, now appears to be a significant resistance level.
→ The B→C retracement is approximately 50% of the A→B decline – a bearish signal.
→ Price movements in 2025 outline a descending trend channel (marked in red), which is becoming increasingly relevant.
If the psychological support level of $300 per TSLA share fails to hold, the price may continue to decline towards the key $270 level. This level acted as resistance to growth in the second half of 2024 but was broken after news of Trump’s victory.
Tesla (TSLA) Share Price Forecast
Analysts remain cautiously optimistic, possibly hoping that Musk’s close ties with Trump will help accelerate the launch of Tesla’s robotaxi service.
Another potential positive driver could be Tesla’s entry into the Indian market.
According to TipRanks:
→ 13 out of 35 surveyed analysts recommend buying TSLA shares;
→ The average 12-month price target for TSLA is $357.
Trade on TradingView with FXOpen. Consider opening an account and access over 700 markets with tight spreads from 0.0 pips and low commissions from $1.50 per lot.
This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
Nightly $SPY / $SPX Scenarios for 2.26.2025🔮 🔮
🌍 Market-Moving News 🌍:
🇺🇸🤔 U.S. Consumer Confidence Dives 🤔: American consumer confidence fell to 98.3 in February (down from 105.3 in January), The steepest one-month drop since 2021.
🇩🇪📉 German GDP Contracts 📉: Germany’s economy shrank by 0.2% in Q4 2024 (quarter-on-quarter), confirming a downturn in Europe’s largest economy. Recession concerns in the Eurozone could influence global growth sentiment as exports and industry show signs of weakness.
🇺🇸💱 Fed Rate Cut Bets Trimmed 💱: Markets are now pricing in only one 25bps rate reduction in 2025 (versus two previously expected),
📊 Key Data Releases 📊:
📅 Wednesday, Feb 26:
🏠 MBA Mortgage Applications (7:00 ET) 🏠: Last week’s applications fell -6.6% amid rising interest rates. Traders will watch if lower demand continues, as higher borrowing costs cool the housing market.
🏠 New Home Sales (10:00 ET) 🏠: Consensus expects around 680K units (vs 698K in December). This Jan report will show if higher mortgage rates are slowing home sales or if housing demand remains resilient to start 2025.
🛢️ EIA Crude Oil Inventories (10:30 ET) 🛢️: Last week, inventories rose to about 432.5 million barrels. A larger-than-expected draw could boost oil prices, while a build might ease price pressures (and inflation concerns).
💬 Fed’s Bostic Speaks (12:00 ET) 💬: Markets will monitor his commentary for any hints on monetary policy or growth/inflation views.
📌 #trading #stockmarket #tomorrow #news #trendtao #charting #technicalanalysis
S&P500 How Expensive Is It?The Average Wage Earner Needs To Work166.5 Hours To Buy One Share Of The S&P500
If this chart does not drive the point home. Nothing will.
Sometimes simple common sense is more powerful than all the fancy analysis one can buy or think of to create.
Price is what you pay, and value is what you get! Remember that my friends.
DANGER IS SCREAMING AT YOU!
NN GROUP ($NN) Q4—INSURANCE CASH SHINES IN EUROPENN GROUP ( EURONEXT:NN ) Q4—INSURANCE CASH SHINES IN EUROPE
(1/9)
Good evening, TradingView! NN Group ( EURONEXT:NN ) is humming—H2 revenue hit $ 7.94B, topping estimates 📈🔥. Q4 earnings and a cash boost spark buzz—let’s unpack this Dutch dynamo! 🚀
(2/9) – REVENUE RUSH
• H2 Haul: $ 7.94B—beats $ 7.41B est. 💥
• Full ‘24: $ 12.36B—up 12% from $ 11.03B 📊
• OCG: $ 1.9B—hits ‘25 goal early
EURONEXT:NN ’s cash flow’s sizzling—steady wins!
(3/9) – BIG MOVES
• Buyback: $ 300M—shares get a lift 🌍
• Dividend: $ 3.44—up 8%, juicy payout 🚗
• Deals: $ 360M settled—risks trimmed 🌟
EURONEXT:NN ’s flexing—insurance muscle shines!
(4/9) – SECTOR SNAP
• P/E: ~10—below 11.9x avg 📈
• P/B: 0.57—vs. sector’s 1.04—cheap?
• Edge: 12% growth tops peers 🌍
EURONEXT:NN ’s a bargain—or just quiet strength?
(5/9) – RISKS ON DECK
• EPS Miss: $ 2.21 vs. $ 3.60—hiccup ⚠️
• Rates: Volatility stings returns 🏛️
• Climate: Claims could climb—yikes 📉
Solid run—can it dodge the bumps?
(6/9) – SWOT: STRENGTHS
• Cash: $ 1.9B OCG—rock solid 🌟
• Payouts: 8% divvy, $ 300M buyback 🔍
• Europe: 20% new biz—growth zip 🚦
EURONEXT:NN ’s a steady beast—built tough!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: EPS slip, Dutch lean 💸
• Opportunities: Eastern Europe perks 🌍
Can EURONEXT:NN zap past the risks?
(8/9) – EURONEXT:NN ’s Q4 cash surge—what’s your vibe?
1️⃣ Bullish—Value shines bright.
2️⃣ Neutral—Solid, risks hover.
3️⃣ Bearish—Misses stall it out.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
EURONEXT:NN ’s $ 7.94B H2 and $ 1.9B OCG spark zing—insurance hums 🌍. Low P/E, but EPS wobbles—gem or pause?
BERKSHIRE HATHAWAY ($BRK.A) Q4—INSURANCE & CASH SHINEBERKSHIRE HATHAWAY ( NYSE:BRK.A ) Q4—INSURANCE & CASH SHINE
(1/9)
Good afternoon, TradingView! Berkshire Hathaway ( NYSE:BRK.A ) is humming—Q4 operating earnings soared 71% to $ 14.5B 📈🔥. Insurance and a record cash pile spark buzz—let’s unpack this titan! 🚀
(2/9) – EARNINGS SURGE
• Q4 Ops: $ 14.5B—up from $ 8.5B last year 💥
• Full ‘24: Insurance jumps 51%—key driver 📊
• Net: $ 19.7B Q4—profit stays juicy
NYSE:BRK.A ’s flexing—steady as she goes!
(3/9) – BIG MOVES
• Cash Hoard: $ 334B—up from $ 270B mid-year 🌍
• No Buybacks: Q4 skips—$ 7B spent earlier 🚗
• Apple Trim: Half sold off—cash king 🌟
Buffett’s stacking bucks—ready for action!
(4/9) – SECTOR SNAP
• Market Cap: ~$ 1.075T—top tier 📈
• P/B: 1.55—vs. JPM’s 1.9, Allstate’s 1.3
• Outrun: 25.5% ‘24 vs. S&P’s 25% 🌍
NYSE:BRK.A ’s a beast—value or peak?
(5/9) – RISKS IN SIGHT
• Stocks: Apple, Chevron swings—volatility nips ⚠️
• Succession: Buffett’s exit looms—jitters? 🏛️
• Economy: Rail, retail soften if cash tightens 📉
Solid, but not ironclad—watch out!
(6/9) – SWOT: STRENGTHS
• Diverse: Insurance leads—51% growth 🌟
• Cash: $ 334B—ultimate cushion 🔍
• Track: 19.8% CAGR—beats S&P’s 10.2% 🚦
NYSE:BRK.A ’s a fortress—built tough!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: Insurance lean, cash sits 💸
• Opportunities: Deals, yields lift—$ 14.5B zing 🌍
Can NYSE:BRK.A zap the next big win?
(8/9) – NYSE:BRK.A ’s Q4 surge—what’s your vibe?
1️⃣ Bullish—Cash rules, value shines.
2️⃣ Neutral—Solid, risks balance.
3️⃣ Bearish—Growth stalls, succession bites.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
NYSE:BRK.A ’s $ 14.5B Q4 and $ 334B cash spark zing—insurance flexes 🌍. Premium P/B, but steady wins—champ or chill?
ARISTA NETWORKS ($ANET) ZAPS Q4—AI & CLOUD FUEL SURGEARISTA NETWORKS ( NYSE:ANET ) ZAPS Q4—AI & CLOUD FUEL SURGE
(1/9)
Good evening, TradingView! Arista Networks ( NYSE:ANET ) is buzzing—$ 7B in 2024 revenue, up 19.5% 📈🔥. Q4 shines with AI and cloud demand—let’s unpack this tech titan! 🚀
(2/9) – REVENUE RUSH
• 2024 Haul: $ 7B—19.5% jump from $ 5.86B 💥
• Q4 Take: $ 1.93B—25.3% up, beats $ 1.9B 📊
• EPS: $ 0.65—tops $ 0.57, up 25%
NYSE:ANET ’s humming—cloud’s got juice!
(3/9) – BIG PLAYS
• Q1 ‘25 Guide: 1.93 − 1.97B—above $ 1.907B 🌍
• Stock Split: 4-for-1—shares for all! 🚗
• AI Ties: Meta, NVIDIA deals spark buzz 🌟
NYSE:ANET ’s wiring the future—full throttle!
(4/9) – SECTOR SNAP
• P/E: ~54—premium vs. Cisco’s 17 📈
• Growth: 19.5% smokes sector’s 7%
• Edge: 70-80% Microsoft share—kingpin 🌍
NYSE:ANET ’s hot—value or stretch?
(5/9) – RISKS IN VIEW
• Clients: Microsoft, Meta—big eggs, one basket ⚠️
• Comp: Cisco bites back—AI race heats 🏛️
• Economy: Capex cuts could sting 📉
High flyer—can it dodge the turbulence?
(6/9) – SWOT: STRENGTHS
• AI Lead: $ 750M ‘25 target—cloud king 🌟
• Margins: 64.6%—profit punch 🔍
• Cash: 95% flow jump, no debt 🚦
NYSE:ANET ’s a lean, mean machine!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: Client lean, high P/E 💸
• Opportunities: AI clusters, enterprise zip 🌍
Can NYSE:ANET zap past the risks?
(8/9) – NYSE:ANET ’s Q4 buzz—what’s your vibe?
1️⃣ Bullish—AI keeps it soaring.
2️⃣ Neutral—Growth’s solid, risks linger.
3️⃣ Bearish—Premium fades fast.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
NYSE:ANET ’s $ 1.93B Q4 and AI deals spark zing—$ 7B year shines 🌍. Premium P/E, but growth rules—champ or chase?
Nike (NKE) Shares Surge 5%Nike (NKE) Shares Surge 5%
The sportswear giant was among the top performers in the US stock market yesterday after Jefferies analysts raised their outlook:
→ Upgraded NKE stock from “Hold” to “Buy”
→ Increased the price target from $75 to $115
Amid fierce competition, NKE shares had been in a downtrend throughout 2023-2024, but a leadership change (which we covered in September 2024) may have acted as a catalyst for a turnaround.
Technical Analysis of Nike (NKE) Stock
Jefferies’ upgrade triggered a bullish breakout of the downtrend line (marked in red).
The $71 level has proven to be a key support, particularly in February, when NKE hit its yearly low. Bears attempted to resume the downtrend, but failed—since then, the stock has surged approximately 17%, forming a sharp reversal (marked by an arrow), which is a bullish signal.
In Wyckoff Method terminology, this move could indicate a Terminal Shakeout, marking a transition from the Accumulation phase to the Mark-Up phase.
Nike (NKE) Stock Forecast
Jefferies analysts hold the most optimistic outlook among their peers. According to TipRanks:
→ 15 out of 28 analysts recommend buying NKE shares
→ The average 12-month price target for NKE is $86
Trade on TradingView with FXOpen. Consider opening an account and access over 700 markets with tight spreads from 0.0 pips and low commissions from $1.50 per lot.
This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
Aditxt (NASDAQ: ADTX) Set for 3,000% Surge Amidst Falling Wedge Aditxt Inc. (NASDAQ: ADTX) is on the brink of a potential game-changing breakout.
We believe NASDAQ: ADTX could deliver a staggering 3,000% surge, presenting a massive short-term opportunity while holding long-term potential as a leader in the biotech space.
About Aditxt Inc. (NASDAQ: ADTX)
Aditxt Inc. (NASDAQ: ADTX), a cutting-edge biotechnology company founded in 2017 and headquartered in Richmond, Virginia, is revolutionizing immune system monitoring and modulation through its groundbreaking technologies aimed at improving health outcomes. Operating within the healthcare sector, Aditxt specializes in developing and commercializing innovative solutions such as AditxtScore, a pioneering platform designed to help individuals understand, manage, and monitor their immune profiles, offering critical insights into immune responses and potential threats.
Technical Overview
Aditxt Inc. (NASDAQ: ADTX) shares have seen a 5.35% decline in the past 24 hours, currently trading within a steep falling wedge pattern—a historically bullish structure that often precedes explosive breakouts. This wedge has been forming since August 2023, signaling a prolonged consolidation phase. With RSI at 19, ADTX is in deeply oversold territory, making it an attractive setup for a significant reversal.
The support level has already been established, preventing further downside pressure. If ADTX breaks above the 38.2% Fibonacci retracement level, it could act as the catalyst for a 3,000% surge, as traders recognize the wedge breakout and align with the strengthening biotech sector trend.
Despite being listed on NASDAQ, ADTX has an intraday market cap of just $6.879 million, an unusually low valuation given its positioning. This makes it a prime candidate for a revaluation, especially as trading volume continues to rise, indicating increased interest from buyers.
Further reinforcing the bullish thesis is the fact that ADTX is trading below the 50-day, 100-day, and 200-day moving averages. Historically, when a stock is far below these levels with growing volume, it often signals a reversal is on the horizon. The combination of a tight trading range, declining seller pressure, and increasing accumulation suggests that ADTX is nearing a breakout point, with technical conditions aligning for a massive upward move.
#Sponsored
Nightly $SPY / $SPX Scenarios for 2.25.2025🔮 Nightly AMEX:SPY / SP:SPX Scenarios for 2.25.2025 🔮
🌍 Market-Moving News 🌍:
🇺🇸📈 U.S. Tariffs on Canada and Mexico 📈: President Donald Trump has confirmed that tariffs on imports from Canada and Mexico will proceed on March 4, 2025. This decision may impact trade relations and market dynamics.
🇰🇷💰 Bank of Korea Rate Cut 💰: The Bank of Korea is expected to reduce its key interest rate by 25 basis points to 2.75% on February 25, aiming to support economic growth amid recent slowdowns.
📊 Key Data Releases 📊:
📅 Tuesday, Feb 25:
🏠 S&P CoreLogic Case-Shiller National Home Price Index (9:00 AM ET) 🏠: Provides data on home prices across 20 major U.S. cities, offering insights into the housing market trends.
📈 Consumer Confidence Index (10:00 AM ET) 📈: Measures consumer sentiment regarding economic conditions. Analysts forecast a slight dip in February to 102.1 from January's 104.1, indicating potential shifts in consumer behavior.
📌 #trading #stockmarket #economy #news #trendtao #charting #technicalanalysis
Master Your Emotions: The 3 Trading Psychology Hacks Most traders don’t struggle because they lack a strategy—they struggle because emotions get in the way. After coaching hundreds of traders, I’ve seen the same patterns over and over: hesitation, FOMO, revenge trading, and self-doubt.
I get it. I’ve been there too. You see the perfect setup but hesitate. Or worse, you jump in too late and watch the market turn against you. It’s frustrating, but there’s a fix.
In this video, I’m breaking down the biggest trading psychology mistake I see and the simple 3-step process that has helped my students trade with confidence, even in the most volatile markets.
If you’ve ever felt like your emotions are sabotaging your trades, this is for you. Let’s fix it.
Kris/Mindbloome Exchange
Trade Smarter Live Better
MERCADOLIBRE ($MELI) SOARS IN Q4—E-COMMERCE & FINTECH SHINE MERCADOLIBRE ( NASDAQ:MELI ) SOARS IN Q4—E-COMMERCE & FINTECH SHINE
(1/9)
Good evening, Tradingview! MercadoLibre ( NASDAQ:MELI ) is sizzling—Q4 revenue up 37%, a $ 6.1B haul 📈🔥. Fintech and e-commerce fuel a 33% surge—let’s unpack this Latin dynamo! 🚀
(2/9) – REVENUE RUSH
• Q4 Take: $ 6.1B—37% leap, tops $ 5.9B est. 💥
• EPS: $ 12.61—blasts past $ 7.94 hopes 📊
• Net Income: $ 639M—beats $ 402M dreams
NASDAQ:MELI ’s humming—growth’s got zing!
(3/9) – BIG MOVES
• GMV: $ 14.5B—56% jump FX-neutral 🌍
• Payments: $ 58.9B TPV—49% up 🚗
• Credit Boom: $ 6.6B—74% growth 🌟
NASDAQ:MELI ’s flexing muscle—full throttle!
(4/9) – MARKET VIBE
• P/E: ~60—above Amazon’s 40, PDD’s 20 📈
• Growth: 37% smokes peers’ 10%
• Targets: 2,400−3,000—10-38% upside 🌍
Premium price—worth the juice?
(5/9) – RISKS ON DECK
• FX Woes: Brazil, Mexico currencies wobble ⚠️
• Comp: Amazon, locals eye the prize 🏛️
• Rates: $ 6.6B credit—defaults lurk? 📉
Hot run—can it dodge the heat?
(6/9) – SWOT: STRENGTHS
• E-comm: $ 14.5B GMV—LatAm king 🌟
• Fintech: $ 58.9B TPV—Pago’s gold 🔍
• Logistics: 6 new centers—zippy edge 🚦📉
NASDAQ:MELI ’s a double-threat dynamo!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: High P/E, FX swings 💸
• Opportunities: Ad bucks, untapped markets 🌍
Can NASDAQ:MELI zap past the bumps?
(8/9) – NASDAQ:MELI ’s Q4 surge—what’s your vibe?
1️⃣ Bullish—$ 3,000 in sight.
2️⃣ Neutral—Growth’s hot, risks hover.
3️⃣ Bearish—FX bites back.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
NASDAQ:MELI ’s $ 6.1B Q4 and fintech flex spark buzz—$ 14.5B GMV shines 🌍🪙. High P/E, but growth rules—champ or chase?
VERTEX ($VRTX) SHINES IN Q4—PAIN & CF FUEL GROWTHVERTEX ( NASDAQ:VRTX ) SHINES IN Q4—PAIN & CF FUEL GROWTH
(1/9)
Good evening, Tradingview! Vertex ( NASDAQ:VRTX ) is buzzing—Q4 revenue up 16%, new drugs hit the scene 📈🔥. $ 2.91B and a bold 2025 forecast—let’s unpack this biotech beast! 🚀
(2/9) – REVENUE RUSH
• Q4 Haul: $ 2.91B—16% jump from last year 💥
• Full ‘24: $ 11.02B, up 12%—Trikafta’s king 📊
• ‘25 Outlook: $11.75-$ 12B—6-9% growth
NYSE:CF keeps humming—newbies add zest!
(3/9) – BIG WINS
• Journavx: Non-opioid painkiller greenlit Jan ‘25 🌍
• Alyftrek: CF drug for 6+—ships now 🚗
• Cash: $11.2B—loaded for action 🌟
NASDAQ:VRTX storms pain—CF stays golden!
(4/9) – SECTOR CHECK
• Valuation: 11x sales—above 9x avg 📈
• Vs. Peers: Gilead’s 4x, Regeneron’s 8x—premium?
• Growth: 12% beats biotech’s 5-7% 🌍
NASDAQ:VRTX flexes—value or stretch?
(5/9) – RISKS ON TAP
• Payers: Journavx needs coverage—hiccups? ⚠️
• Trikafta: 93% of sales—big lean 🏛️
• Comp: Pain rivals, CF safe—for now 📉
Hot streak—can it dodge the bumps?
(6/9) – SWOT: STRENGTHS
• CF King: Trikafta, Alyftrek lock it in 🌟
• Pain Play: Journavx eyes $ 4B peak 🔍
• Cash: $11.2B—war chest ready 🚦
NASDAQ:VRTX ’s got muscle and moolah!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: Trikafta reliance—eggs in one basket 💸
• Opportunities: Casgevy rolls, pain grows 🌍
Can NASDAQ:VRTX zap past the risks?
(8/9) – NASDAQ:VRTX ’s Q4 surge—what’s your vibe?
1️⃣ Bullish—Pain pays off big.
2️⃣ Neutral—Solid, but risks linger.
3️⃣ Bearish—Growth hits a wall.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
NASDAQ:VRTX ’s $2.91B Q4 and Journavx/Alyftrek wins spark buzz—$11.2B cash backs it 🌍🪙. Trikafta rules, risks hover—champ or chaser?
CELSIUS ($CELH) ZAPS UP 33%—Q4 & ALANI NU IGNITE BUZZCELSIUS ( NASDAQ:CELH ) ZAPS UP 33%—Q4 & ALANI NU IGNITE BUZZ
(1/9)
Good evening, Tradingview! Celsius Holdings ( NASDAQ:CELH ) just surged 33%—Q4 earnings and a $1.65B Alani Nu buyout lit the fuse 📈🔥. Energy drink market’s buzzing—let’s unpack this jolt! 🚀
(2/9) – EARNINGS SNAP
• Q4 Revenue: $332M, topped $329M expected 💥
• Margin: Jumped to 50.2%—beats 47.1% hopes 📊
• EPS: $0.14, above $0.11—solid grit
Growth slowed, but NASDAQ:CELH flexed resilience!
(3/9) – ALANI NU DEAL
• Price: $1.65B—$1.275B cash, $500M stock 🌍
• Alani’s Pull: $595M ‘24 sales, 78% growth 🚗
• Combo: 16% energy drink share—$ 2B ‘25 goal 🌟
NASDAQ:CELH snags a rival—big playtime!
(4/9) – MARKET VIBE
• Surge: 33% to $33-$35—shorts burned 📈
• Vs. Peers: 6x sales, below 9x avg—value?
• X Hype: “Top gainer”—bulls cheer 🌍
NASDAQ:CELH heats up—bargain or buzz?
(5/9) – RISKS IN SIGHT
• Overlap: Alani vs. CELH—cannibal clash? ⚠️
• Slowdown: North Am. down 6%—Pepsi hiccups 🏛️
• Comp: Rivals eye shelf space—tight race 📉
Hot move, but bumps lurk ahead!
(6/9) – SWOT: STRENGTHS
• Deal: $1.65B Alani—growth rocket 🌟
• Margin: 50.2%—profit punch 🔍
• Global: 39% intl. leap—worldwide zip 🚦
NASDAQ:CELH ’s firing on all cylinders!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: Q4 dip, overlap risks 💸
• Opportunities: $ 2B sales, $50M synergies 🌍
Can NASDAQ:CELH juice up the doubters?
(8/9) – NASDAQ:CELH ’s 33% zap—what’s your vibe?
1️⃣ Bullish—$40+ in sight.
2️⃣ Neutral—Growth’s cool, risks hover.
3️⃣ Bearish—Hype fades fast.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
NASDAQ:CELH ’s Q4 and Alani Nu deal spark a 33% leap—$332M, $1.65B buy 🌍🪙. Resilience shines, but overlap looms—champ or chase?
AAPLAAPL price is in a correction phase. Now the price is near the resistance zone. If the price cannot break through 259, it is expected that the price will drop. Consider selling the red zone.
🔥Trading futures, forex, CFDs and stocks carries a risk of loss.
Please consider carefully whether such trading is suitable for you.
>>GooD Luck 😊
❤️ Like and subscribe to never miss a new idea!
$US30 DOW JONES—STEADY AMID THE STORMDOW JONES—STEADY AMID THE STORM
(1/9)
Good morning, Tradingview! The Dow Jones is the cool-headed cousin—less wild than Nasdaq’s growth party 📈🔥. Blue-chip stability shines, even as inflation bites—let’s unpack it! 🚀
(2/9) – WHY SO CALM?
• Makeup: 30 big, steady names—Walmart, Goldman 💥
• Price-Weighted: High flyers lead, not tech zingers 📊
• Edge: Less sway from growth stock swings
Dow’s the tortoise—slow and steady wins?
(3/9) – RECENT VIBES
• Feb 22: 1.7% dip—support at 43,400 holds 🌍
• VIX: Stays chill—Nasdaq would’ve freaked 🚗
• CPI Hit: 400-point drop, 300 back—meh 🌟
Stability’s the Dow’s secret sauce!
(4/9) – SECTOR SNAP
• Vs. Nasdaq: Tech’s jittery—Dow’s diversified 📈
• Volatility: ~15-20% vs. Nasdaq’s 25-30%
• Champs: Blue-chips buffer the chaos
Steadier ship—less Nasdaq nuttiness! 🌍
(5/9) – INFLATION RIPPLES
• CPI Spike: 3% YoY—400-point jolt ⚠️
• Fed: No rush to cut—rates sting 🏛️
• X Buzz: Tariffs, inflation spook recovery 📉
Even the Dow feels the heat—but shrugs!
(6/9) – SWOT: STRENGTHS
• Stability: Blue-chip backbone holds firm 🌟
• Dividends: Cash flows steady the ship 🔍
• Mix: Less tech tantrums—broad base 🚦
Dow’s the rock in choppy waters!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: Inflation nicks costs—ouch 💸
• Opportunities: Safety shines if tech flops 🌍
Can Dow dodge the inflation blues?
(8/9) – Dow’s steady play—what’s your vibe?
1️⃣ Bullish—Stability’s golden.
2️⃣ Neutral—Holds, but inflation looms.
3️⃣ Bearish—Growth wins anyway.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
Dow’s less jittery—blue-chips cushion the storm 🌍🪙. Inflation’s a nag, but stability rules. Rock or relic?
EURO LIFTS POST-GERMAN VOTE—BUT USD BITES BACKEURO LIFTS POST-GERMAN VOTE—BUT USD BITES BACK FX:EURUSD
(1/9)
Good morning, Tradingview Fam! Germany’s election—Merz and CDU on top—gave the euro a quick jolt, up 0.44% to $1.0507 📈🔥. Markets dig the stability vibe, but it’s fading fast—let’s unpack this tussle! 🚀
(2/9) – ELECTION SPARK
• Euro Bump: Hit $1.0530 overnight—election cheer 💥
• Markets: DAX futures up 1.2%, EUROSTOXX 50 +0.66% 📊
• Fade: Now at $1.0480—USD’s flexing back
Brief lift—stability’s sweet, but not sticky!
(3/9) – TECH TELLTALE
• Resistance: $1.0500-1.0510 wall holds firm 🌍
• Support: $1.0470 pivot, then $1.0440 if it slips 🚗
• Charts: Double top whispers at $1.0530 🌟
Traders on X see a retreat—bearish juice brewing?
(4/9) – USD PUSHBACK
• Jobless Claims: Weak last week, USD softened a tad 📉
• Fed: No rush to cut—rates steady, Nvidia looms
• Muscle: Dollar’s clawing back—ballast holds
AMEX:USD ’s got grit—euro’s nudge ain’t enough! 🌍
(5/9) – RISKS IN PLAY
• Volatility: PMI data, Nvidia earnings stir the pot ⚠️
• Sentiment: X split—liquidity grab or bear turn? 🏛️
• Levels: Below $1.0470 opens $1.0390 risk 📉
Quick sprint—can euro keep the pace?
(6/9) – SWOT: STRENGTHS
• Election Lift: CDU win sparks euro hope 🌟
• Markets: European futures pop—optimism flows 🔍
• Cash: $1.0530 peak shows buyer guts 🚦
Euro’s got some spark—briefly lit!
(7/9) – SWOT: WEAKNESSES & OPPORTUNITIES
• Weaknesses: $1.0510 cap, USD fights back 💸
• Opportunities: PMI beats could push $1.0600 🌍
Will euro dodge the dollar’s jab?
(8/9) – Euro’s election bump—what’s your call?
1️⃣ Bullish—Stability wins out.
2️⃣ Neutral—Blip, not a trend.
3️⃣ Bearish—USD takes the ring.
Vote below! 🗳️👇
(9/9) – FINAL TAKEAWAY
Euro spiked to $1.0507 on Germany’s vote—CDU’s steady hand 🌍🪙. Now $1.0480—USD’s got claws. Resistance bites, downside looms—blip or bust?